DENA
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
06/08/2026
Voltar para busca
Dado oficial do USPTO
WISTA
Essa marca aparece no histórico oficial do USPTO.
Mesmo quando o status está encerrado, o histórico ajuda a calibrar o risco, evitar repetição de erros e definir uma estratégia segura de naming.
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILEDTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Tipo de processo
Pedido e registro
Eventos registrados
38
Atualização mais recente
06/08/2026
Classificação
Inactive
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
22/12/2015
Data de registro
07/03/2017
Data de expiração
-
Ação recomendada
Use este histórico como insumo para naming, mas confirme disponibilidade atual em todas as classes relevantes.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/12/2025
Última transação
06/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
404
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
98
Localização do titular
SG
Examinador
BAGLINI, KAREN
Unidade examinadora
M80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
TauRx Therapeutics Ltd.
WisTa Laboratories Ltd
Representantes
Thad Chaloemtiarana Pattishall, McAuliffe, Newbury, Hilliard
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical and medical preparations for use in the detectionprevention and treatment of neurological diseases and disordersneurodegenerative diseases and disordersblood disordersinfectious diseases and malaria; chemical preparations for medical and pharmaceutical purposes for use in the detectionprevention and treatment of neurological diseases and disordersneurodegenerative diseases and disordersblood disordersinfectious diseases and malaria; none of the aforesaid being pharmaceutical preparations and substances intended for the prevention and treatment of bone/skeletal diseases
Classe 42
Medicalbiologicalbiotechnologicalgeneticpharmaceutical researchdesign and development services and laboratory research services in the fields of drugspharmaceuticals and medicines; researchdevelopment and design of drugs and medicine; drug discovery services; laboratory and medical laboratory research and development services relating to drugspharmaceuticals and medicines; exploitation of scientific research and technologyproviding advice and information relating to scientific and technological research in the fields of drugspharmaceuticals and medicinesin the fields of drug developmentclinical trial designpatient recruitmentdrug testingclinical data managementdata analysisstatistical analysispatient selectionclinical diagnosis and diagnostic testing; researching and developing new products in the fields of drugspharmaceuticals and medicines; scientific research and development services in the fields of drug developmentclinical trial designpatient recruitmentdrug testingclinical data managementdata analysisstatistical analysispatient selectionclinical diagnosis and diagnostic testing; preparation of reports of scientific and medical research concerning drugspharmaceuticalsmedicinesgeneticsbiology and biotechnology; development and design of medical or scientific prognostic and diagnostic apparatus and instruments; consultancy and information services relating to all of the aforesaid
Publicações
Histórico de despachos e eventos da marca no USPTO.
38 publicações encontradas
DETH
DEATH OF INTERNATIONAL REGISTRATION
06/08/2026
CHLD
CHANGE OF OWNER RECEIVED FROM IB
20/11/2025
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
14/07/2024
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
24/06/2024
INPC
INVALIDATION PROCESSED
24/06/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
14/06/2024
C71T
CANCELLED SECTION 71
22/09/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
07/03/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/07/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
19/06/2017
FIMP
FINAL DISPOSITION PROCESSED
19/06/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/06/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
07/03/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/12/2016
PUBO
PUBLISHED FOR OPPOSITION
20/12/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/11/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
16/11/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/11/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/11/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/11/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/10/2016
GNRT
NON-FINAL ACTION E-MAILED
06/10/2016
CNRT
NON-FINAL ACTION WRITTEN
06/10/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/09/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/09/2016
ALIE
ASSIGNED TO LIE
10/09/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/09/2016
RFNT
REFUSAL PROCESSED BY IB
13/05/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
15/04/2016
RFRR
REFUSAL PROCESSED BY MPU
15/04/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
15/04/2016
CNRT
NON-FINAL ACTION WRITTEN
14/04/2016
DOCK
ASSIGNED TO EXAMINER
11/04/2016
MAFR
APPLICATION FILING RECEIPT MAILED
27/02/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/02/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/02/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace WISTA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.